American Journal of Neuroradiology 25:1524-1532, October 2004
© 2004 American Society of Neuroradiology
BRAIN
Characterization of a First-Pass Gradient-Echo Spin-Echo Method to Predict Brain Tumor Grade and Angiogenesis
a Department of Radiology, Medical College of Wisconsin, Milwaukee, WI
b Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI
c Departments of Neurology and Neurosurgery, Medical College of Wisconsin, Milwaukee, WI
d Department of Biomedical Engineering, Marquette University, Milwaukee, WI
Address reprint requests to Kathleen M. Schmainda, PhD, Medical College of Wisconsin, Department of Biophysics, 8701 Watertown Plank Rd, Milwaukee, WI 53226
BACKGROUND AND PURPOSE: No widespread clinical method provides specific information about the angiogenic characteristics of gliomas. We characterized blood volume and vascular morphologic parameters from combined gradient-echo (GE) and spin-echo (SE) MR imaging and assessed their relationship to tumor grade, a known correlate of glioma angiogenesis.
METHODS: Simultaneous GE and SE echo-planar imaging was performed with bolus gadolinium administration (0.200.25 mmol/kg) in 73 patients with glioma. To diminish possible T1 changes due to contrast agent extravasation, a preload (0.050.10 mmol/kg) was administered before the study, and a postprocessing correction algorithm was applied. Image maps of total (GE) and microvascular (SE) relative cerebral blood volume (rCBV) and the mean vessel diameter (mVD) calculated from the ratio of GE and SE relaxation rate changes (
R2*/
R2) were compared with tumor grade. A nonparametric K nearest-neighbor decision rule was applied to determine if the combined data could be used to distinguish low-grade (III) from high-grade (IIIIV) tumors on a per-patient basis.
RESULTS: For whole tumors, significant correlations were found between GE rCBV and grade (P < .0001) and between mVD and grade (P = .0001) but not between SE rCBV and grade (P = .08). For areas of highest SE rCBV (microvascular hotspots), SE rCBV and tumor grade were significantly correlated (P = .0007). In terms of differentiation, 69% of low-grade tumors and 96% of high-grade tumors were correctly classified.
CONCLUSION: Combined GE and SE MR imaging provides information consistent with neoplastic angiogenesis, demonstrating its potential to aid in optimizing treatments, categorizing lesions, and influencing patient care.
This article has been cited by other articles:
![]() |
C. T. Farrar, W. S. Kamoun, C. D. Ley, Y. R. Kim, S. J. Kwon, G. Dai, B. R. Rosen, E. di Tomaso, R. K. Jain, and A. G. Sorensen In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model Neuro Oncology, January 11, 2010; (2010) nop032v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Valable, D. Eddi, J.-M. Constans, J.-S. Guillamo, M. Bernaudin, S. Roussel, and E. Petit MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor model Neuro Oncology, October 1, 2009; 11(5): 488 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Gasparetto, M. A. Pawlak, S. H. Patel, J. Huse, J. H. Woo, J. Krejza, M. R. Rosenfeld, D. M. O'Rourke, R. Lustig, E. R. Melhem, et al. Posttreatment Recurrence of Malignant Brain Neoplasm: Accuracy of Relative Cerebral Blood Volume Fraction in Discriminating Low from High Malignant Histologic Volume Fraction Radiology, March 1, 2009; 250(3): 887 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Sorensen Perfusion MR Imaging: Moving Forward Radiology, November 1, 2008; 249(2): 416 - 417. [Full Text] [PDF] |
||||
![]() |
E. S. Paulson and K. M. Schmainda Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors Radiology, November 1, 2008; 249(2): 601 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-G. Vezina Imaging of Central Nervous System Tumors in Children: Advances and Limitations J Child Neurol, October 1, 2008; 23(10): 1128 - 1135. [Abstract] [PDF] |
||||
![]() |
K.E. Emblem, D. Scheie, P. Due-Tonnessen, B. Nedregaard, T. Nome, J.K. Hald, K. Beiske, T.R. Meling, and A. Bjornerud Histogram Analysis of MR Imaging-Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes AJNR Am. J. Neuroradiol., October 1, 2008; 29(9): 1664 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Emblem, B. Nedregaard, T. Nome, P. Due-Tonnessen, J. K. Hald, D. Scheie, O. C. Borota, M. Cvancarova, and A. Bjornerud Glioma Grading by Using Histogram Analysis of Blood Volume Heterogeneity from MR-derived Cerebral Blood Volume Maps Radiology, June 1, 2008; 247(3): 808 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, R. J. Young, J. S. Babb, N. Peccerelli, S. Chheang, M. L. Gruber, D. C. Miller, J. G. Golfinos, D. Zagzag, and G. Johnson Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Radiology, May 1, 2008; 247(2): 490 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
C W Ryu, D H Lee, H S Kim, J H Lee, C G Choi, S J Kim, and D C Suh Acquisition of MR perfusion images and contrast-enhanced MR angiography in acute ischaemic stroke patients: which procedure should be done first? Br. J. Radiol., December 1, 2006; 79(948): 962 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Sorensen Magnetic Resonance As a Cancer Imaging Biomarker J. Clin. Oncol., July 10, 2006; 24(20): 3274 - 3281. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Boxerman, K.M. Schmainda, and R.M. Weisskoff Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 859 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, S. Oh, J. S. Babb, E. Wang, M. Inglese, D. Zagzag, E. A. Knopp, and G. Johnson Low-Grade Gliomas: Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging--Prediction of Patient Clinical Response Radiology, February 1, 2006; 238(2): 658 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bulakbasi, M. Kocaoglu, A. Farzaliyev, C. Tayfun, T. Ucoz, and I. Somuncu Assessment of Diagnostic Accuracy of Perfusion MR Imaging in Primary and Metastatic Solitary Malignant Brain Tumors AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2187 - 2199. [Abstract] [Full Text] [PDF] |
||||





